To mark Rare Disease day 2010, representatives from pharmaceutical industry met with patient representatives from Rare Disorders Denmark to discuss Orphan drugs - is there any upper limit to how much should be spent on a single patient?
Choose view to display graphs per topic.
| Topic | Results |
|---|---|
| Orphan drugs | view |
This is an overview of all sessions played at the event for which the results have been uploaded. Click on any session to see the votes on the policies.
| Decide Sessions | Topics |
|---|---|
| Rare Disease day - patients meets pharma - Finns det en övre gräns för hur mycket pengar som en enskild patient får kosta? – Frågan om särläkemedel | Finns det en övre gräns för hur mycket pengar som en enskild patient får kosta? – Frågan om särläkemedel |
FUND is a project funded by the European Commission (grant agreement SiS-CT-2009-230474). The views and opinions here expressed do not necessarily reflect those of the European Community and the Community is not liable for any use that may be made of the information contained therein.